The effect of interferon beta-1a on spasticity in primary progressive multiple sclerosis

To investigate this phenomenon further, we conducted a retrospective analysis of the spasticity studied in the recently published randomised controlled trial of interferon beta-1a in PPMS. 2 We randomised 50 subjects to receive weekly for two years an intramuscular injection of either interferon bet...

Full description

Saved in:
Bibliographic Details
Published in:Journal of neurology, neurosurgery and psychiatry neurosurgery and psychiatry, 2004-03, Vol.75 (3), p.508-509
Main Authors: Leary, S M, Thompson, A J
Format: Article
Language:English
Subjects:
Adjuvants, Immunologic - pharmacology
Care and treatment
Complications and side effects
Disease Progression
Double-Blind Method
Humans
Injections, Intramuscular
Interferon
Interferon beta
Interferon beta-1a
Interferon-beta - pharmacology
Letter
Multiple sclerosis
Multiple Sclerosis - complications
Muscle Spasticity - drug therapy
Muscle Spasticity - etiology
Placebos
Retrospective Studies
Treatment Outcome
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-b571t-230f4507d73919836697fbb90c58dd23876bd4ceeed8633427b45e11bf909e113
cites
container_end_page 509
container_issue 3
container_start_page 508
container_title Journal of neurology, neurosurgery and psychiatry
container_volume 75
creator Leary, S M
Thompson, A J
description To investigate this phenomenon further, we conducted a retrospective analysis of the spasticity studied in the recently published randomised controlled trial of interferon beta-1a in PPMS. 2 We randomised 50 subjects to receive weekly for two years an intramuscular injection of either interferon beta-1a 30 [micro]g (15 subjects); or interferon beta-1a 60 [micro]g (15 subjects); or placebo (20 subjects).
doi_str_mv 10.1136/jnnp.2003.018598
format article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1738962</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A114594006</galeid><sourcerecordid>A114594006</sourcerecordid><originalsourceid>FETCH-LOGICAL-b571t-230f4507d73919836697fbb90c58dd23876bd4ceeed8633427b45e11bf909e113</originalsourceid><addsrcrecordid>eNqFkstv1DAQxiMEokvhzglFQuoFZZmJEz8uSNWWl6jKgVIqLlYe462XxFnspKL_PV5l1QKqhH0Yy_P7ZuzRlyTPEZaIjL_eOLdd5gBsCShLJR8kCyy4zBiDy4fJAiDPMwYlHCRPQtjAbkn1ODnAQnGOEhfJ5fkVpWQMNWM6mNS6kbwhP7i0prHKsErjMWyrMNrGjjcRSLfe9pW_iXFYewrBXlPaT91otx2loemiOtjwNHlkqi7Qs308TL6-e3u--pCdfn7_cXV8mtWlwDHLGZiiBNEKplBJxrkSpq4VNKVs25xJweu2aIiolZyxIhd1URJibRSoGNlh8mauu53qntqG3OirTu8fqYfK6r8zzl7p9XCtUTCpeB4LHO0L-OHnRGHUvQ0NdV3laJiCloAcoWARfPkPuBkm7-LnYi2JOStQiEhlM7WuOtLWmSF2bdbkKDYfHBkbr48Ri1IVADzyy3v4uFvqbXOvAGZBE-ccPJnbvyLonSv0zhV65wo9uyJKXvw5ozvB3gZ3j7ZhpF-3-cr_0FwwUeqzi5U-gYuTb9-_nOlPkX8183W_-X_738Hg0E4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1781234177</pqid></control><display><type>article</type><title>The effect of interferon beta-1a on spasticity in primary progressive multiple sclerosis</title><source>PubMed Central</source><creator>Leary, S M ; Thompson, A J</creator><creatorcontrib>Leary, S M ; Thompson, A J</creatorcontrib><description>To investigate this phenomenon further, we conducted a retrospective analysis of the spasticity studied in the recently published randomised controlled trial of interferon beta-1a in PPMS. 2 We randomised 50 subjects to receive weekly for two years an intramuscular injection of either interferon beta-1a 30 [micro]g (15 subjects); or interferon beta-1a 60 [micro]g (15 subjects); or placebo (20 subjects).</description><identifier>ISSN: 0022-3050</identifier><identifier>EISSN: 1468-330X</identifier><identifier>DOI: 10.1136/jnnp.2003.018598</identifier><identifier>PMID: 14966181</identifier><identifier>CODEN: JNNPAU</identifier><language>eng</language><publisher>England: BMJ Publishing Group Ltd</publisher><subject>Adjuvants, Immunologic - pharmacology ; Care and treatment ; Complications and side effects ; Disease Progression ; Double-Blind Method ; Humans ; Injections, Intramuscular ; Interferon ; Interferon beta ; Interferon beta-1a ; Interferon-beta - pharmacology ; Letter ; Multiple sclerosis ; Multiple Sclerosis - complications ; Muscle Spasticity - drug therapy ; Muscle Spasticity - etiology ; Placebos ; Retrospective Studies ; Treatment Outcome</subject><ispartof>Journal of neurology, neurosurgery and psychiatry, 2004-03, Vol.75 (3), p.508-509</ispartof><rights>Copyright 2004 Journal of Neurology Neurosurgery and Psychiatry</rights><rights>COPYRIGHT 2004 BMJ Publishing Group Ltd.</rights><rights>Copyright: 2004 Copyright 2004 Journal of Neurology Neurosurgery and Psychiatry</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b571t-230f4507d73919836697fbb90c58dd23876bd4ceeed8633427b45e11bf909e113</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1738962/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1738962/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14966181$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Leary, S M</creatorcontrib><creatorcontrib>Thompson, A J</creatorcontrib><title>The effect of interferon beta-1a on spasticity in primary progressive multiple sclerosis</title><title>Journal of neurology, neurosurgery and psychiatry</title><addtitle>J Neurol Neurosurg Psychiatry</addtitle><description>To investigate this phenomenon further, we conducted a retrospective analysis of the spasticity studied in the recently published randomised controlled trial of interferon beta-1a in PPMS. 2 We randomised 50 subjects to receive weekly for two years an intramuscular injection of either interferon beta-1a 30 [micro]g (15 subjects); or interferon beta-1a 60 [micro]g (15 subjects); or placebo (20 subjects).</description><subject>Adjuvants, Immunologic - pharmacology</subject><subject>Care and treatment</subject><subject>Complications and side effects</subject><subject>Disease Progression</subject><subject>Double-Blind Method</subject><subject>Humans</subject><subject>Injections, Intramuscular</subject><subject>Interferon</subject><subject>Interferon beta</subject><subject>Interferon beta-1a</subject><subject>Interferon-beta - pharmacology</subject><subject>Letter</subject><subject>Multiple sclerosis</subject><subject>Multiple Sclerosis - complications</subject><subject>Muscle Spasticity - drug therapy</subject><subject>Muscle Spasticity - etiology</subject><subject>Placebos</subject><subject>Retrospective Studies</subject><subject>Treatment Outcome</subject><issn>0022-3050</issn><issn>1468-330X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><recordid>eNqFkstv1DAQxiMEokvhzglFQuoFZZmJEz8uSNWWl6jKgVIqLlYe462XxFnspKL_PV5l1QKqhH0Yy_P7ZuzRlyTPEZaIjL_eOLdd5gBsCShLJR8kCyy4zBiDy4fJAiDPMwYlHCRPQtjAbkn1ODnAQnGOEhfJ5fkVpWQMNWM6mNS6kbwhP7i0prHKsErjMWyrMNrGjjcRSLfe9pW_iXFYewrBXlPaT91otx2loemiOtjwNHlkqi7Qs308TL6-e3u--pCdfn7_cXV8mtWlwDHLGZiiBNEKplBJxrkSpq4VNKVs25xJweu2aIiolZyxIhd1URJibRSoGNlh8mauu53qntqG3OirTu8fqYfK6r8zzl7p9XCtUTCpeB4LHO0L-OHnRGHUvQ0NdV3laJiCloAcoWARfPkPuBkm7-LnYi2JOStQiEhlM7WuOtLWmSF2bdbkKDYfHBkbr48Ri1IVADzyy3v4uFvqbXOvAGZBE-ccPJnbvyLonSv0zhV65wo9uyJKXvw5ozvB3gZ3j7ZhpF-3-cr_0FwwUeqzi5U-gYuTb9-_nOlPkX8183W_-X_738Hg0E4</recordid><startdate>20040301</startdate><enddate>20040301</enddate><creator>Leary, S M</creator><creator>Thompson, A J</creator><general>BMJ Publishing Group Ltd</general><general>BMJ Publishing Group LTD</general><general>BMJ Group</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>88I</scope><scope>8AF</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>M2P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20040301</creationdate><title>The effect of interferon beta-1a on spasticity in primary progressive multiple sclerosis</title><author>Leary, S M ; Thompson, A J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b571t-230f4507d73919836697fbb90c58dd23876bd4ceeed8633427b45e11bf909e113</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adjuvants, Immunologic - pharmacology</topic><topic>Care and treatment</topic><topic>Complications and side effects</topic><topic>Disease Progression</topic><topic>Double-Blind Method</topic><topic>Humans</topic><topic>Injections, Intramuscular</topic><topic>Interferon</topic><topic>Interferon beta</topic><topic>Interferon beta-1a</topic><topic>Interferon-beta - pharmacology</topic><topic>Letter</topic><topic>Multiple sclerosis</topic><topic>Multiple Sclerosis - complications</topic><topic>Muscle Spasticity - drug therapy</topic><topic>Muscle Spasticity - etiology</topic><topic>Placebos</topic><topic>Retrospective Studies</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Leary, S M</creatorcontrib><creatorcontrib>Thompson, A J</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Psychology Database</collection><collection>Science Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of neurology, neurosurgery and psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Leary, S M</au><au>Thompson, A J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The effect of interferon beta-1a on spasticity in primary progressive multiple sclerosis</atitle><jtitle>Journal of neurology, neurosurgery and psychiatry</jtitle><addtitle>J Neurol Neurosurg Psychiatry</addtitle><date>2004-03-01</date><risdate>2004</risdate><volume>75</volume><issue>3</issue><spage>508</spage><epage>509</epage><pages>508-509</pages><issn>0022-3050</issn><eissn>1468-330X</eissn><coden>JNNPAU</coden><abstract>To investigate this phenomenon further, we conducted a retrospective analysis of the spasticity studied in the recently published randomised controlled trial of interferon beta-1a in PPMS. 2 We randomised 50 subjects to receive weekly for two years an intramuscular injection of either interferon beta-1a 30 [micro]g (15 subjects); or interferon beta-1a 60 [micro]g (15 subjects); or placebo (20 subjects).</abstract><cop>England</cop><pub>BMJ Publishing Group Ltd</pub><pmid>14966181</pmid><doi>10.1136/jnnp.2003.018598</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-3050
ispartof Journal of neurology, neurosurgery and psychiatry, 2004-03, Vol.75 (3), p.508-509
issn 0022-3050
1468-330X
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1738962
source PubMed Central
subjects Adjuvants, Immunologic - pharmacology
Care and treatment
Complications and side effects
Disease Progression
Double-Blind Method
Humans
Injections, Intramuscular
Interferon
Interferon beta
Interferon beta-1a
Interferon-beta - pharmacology
Letter
Multiple sclerosis
Multiple Sclerosis - complications
Muscle Spasticity - drug therapy
Muscle Spasticity - etiology
Placebos
Retrospective Studies
Treatment Outcome
title The effect of interferon beta-1a on spasticity in primary progressive multiple sclerosis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T04%3A34%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20effect%20of%20interferon%20beta-1a%20on%20spasticity%20in%20primary%20progressive%20multiple%20sclerosis&rft.jtitle=Journal%20of%20neurology,%20neurosurgery%20and%20psychiatry&rft.au=Leary,%20S%20M&rft.date=2004-03-01&rft.volume=75&rft.issue=3&rft.spage=508&rft.epage=509&rft.pages=508-509&rft.issn=0022-3050&rft.eissn=1468-330X&rft.coden=JNNPAU&rft_id=info:doi/10.1136/jnnp.2003.018598&rft_dat=%3Cgale_pubme%3EA114594006%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b571t-230f4507d73919836697fbb90c58dd23876bd4ceeed8633427b45e11bf909e113%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1781234177&rft_id=info:pmid/14966181&rft_galeid=A114594006&rfr_iscdi=true